| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 3,250,650 | 5,106,872 | 2,887,874 | 887,212 |
| Prepaid insurance | 56,031 | 26,682 | 29,490 | 14,597 |
| Other prepaid expenses | 101,069 | 44,825 | 61,839 | 87,943 |
| Digital assets | NaN | NaN | 2,454,473 | NaN |
| Total current assets | 3,407,750 | 5,178,379 | 5,433,676 | 989,752 |
| Light proton therapy system equipment | 6,607,419 | 6,582,560 | NaN | NaN |
| Deferred offering costs | NaN | NaN | NaN | 198,826 |
| Operating lease right-of-use assets | 850,129 | 972,682 | NaN | NaN |
| Total assets | 10,865,298 | 12,733,621 | 5,433,676 | 1,188,578 |
| Related parties accounts payable and accrued expenses | 391,081 | 436,482 | 235,900 | 92,149 |
| Research and development contract liabilities | 238,435 | 232,138 | 235,155 | 256,147 |
| Operating lease obligations, current | 595,418 | 595,418 | NaN | NaN |
| Accrued offering costs | NaN | NaN | NaN | 188,826 |
| Series b convertible preferred stock 8 cumulative dividend payable | NaN | 69,073 | 50,367 | NaN |
| Total current liabilities | 1,224,934 | 1,333,111 | 521,422 | 537,122 |
| Operating lease obligations, long-term | 461,772 | 438,959 | NaN | NaN |
| Total liabilities | 1,686,706 | 1,772,070 | NaN | NaN |
| Preferred stock, value | NaN | 1,731,569 | 2,553,359 | NaN |
| Common stock, 0.0001 par value 100,000,000 shares authorized 11,632,944 and 8,790,102 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1,162 | 879 | 570 | 276 |
| Additional paid-in capital | 67,944,759 | 66,008,824 | 57,891,644 | 54,204,101 |
| Accumulated deficit | -60,000,889 | -58,077,213 | -55,533,319 | -53,552,921 |
| Total lixte biotechnology stockholders equity | 7,945,032 | 9,664,059 | 4,912,254 | 651,456 |
| Non-controlling interest | 1,233,560 | 1,297,492 | NaN | NaN |
| Total stockholders equity | 9,178,592 | 10,961,551 | NaN | NaN |
| Total liabilities and stockholders equity | 10,865,298 | 12,733,621 | 5,433,676 | 1,188,578 |
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)